US AI for Elderly Care Market - Strategic Insights and Forecasts (2026-2031)

The US AI for Elderly Care market is projected for significant expansion, growing from USD 3.3 billion in 2026 to USD 9.1 billion by 2031. This forecast indicates a robust Compound Annual Growth Rate (CAGR) of 22.5%, driven by the pressing demographic imperative of an ageing US population.

The market's growth is primarily fueled by the undeniable demographic shift of the ageing US population, with baby boomers surpassing 65 by 2030. Additionally, a favorable reimbursement landscape, specifically extensions and clarifications by CMS for Remote Patient Monitoring (RPM) services, acts as a significant catalyst by reducing financial barriers for institutional adoption.

The US AI for Elderly Care market involves the deployment of key AI technologies such as Machine Learning algorithms, Natural Language Processing (NLP), and Computer Vision. These technologies underpin proactive, personalized care solutions, including early Fall Detection and Prevention, sophisticated Medication Management, and the provision of Social Interaction and Companionship for the ageing population.

AI systems within this market are procured by a dual set of stakeholders: individual caregivers and healthcare institutions. This includes Home Care Settings and assisted living facilities, which seek AI-powered solutions to augment human staff capacity, automate routine tasks, and ensure quality of life for the elderly.

Regulatory influence includes an escalating focus from the Department of Health and Human Services (HHS) on mitigating algorithmic bias and ensuring equitable access, alongside the FDA's streamlined authorization for AI-enabled medical devices. Economically, the US imposition of tariffs on electronic components and finished medical devices from key sourcing regions introduces cost headwinds, particularly for hardware-dependent solutions like AI Robotics and advanced sensor hardware.

Yes, a key challenge is the cost headwind introduced by tariffs. The US imposition of significant tariffs on electronic components and finished medical devices from key sourcing regions elevates the manufacturing costs of AI Robotics and advanced sensor Hardware. This factor poses a constraint on affordability and market penetration, particularly for device-centric AI solutions in elderly care.